Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Millipore Appoints New Bioscience Division President

Millipore Corporation (Millipore) has appointed Jon DiVincenzo as president for its Bioscience Division and member to its corporate executive committee. DiVincenzo assumed his new role on January 1, 2009, succeeding Dominique Baly, who left Millipore at the end of December, 2008. Since he joined Millipore in 1994, DiVincenzo has held a number of key senior management positions within the Bioscience Division.

Most recently serving as vice president of global sales and service and vice president of marketing and R&D. He has also held several senior marketing and product management positions within Millipore’s Lab Water business (now part of the Bioscience Division).

Prior to joining Millipore, DiVincenzo worked for Orion Research (now Thermo Fisher Scientific) in technical support and product management positions, and for General Electric Corporation in thermodynamics engineering. He holds a bachelor’s degree in Mechanical Engineering from Northeastern University.

“Jon brings to his new position a wealth of leadership experience and an in-depth understanding of the life science markets,” said Martin Madaus, Millipore Chairman, president and chief executive officer. “In his 15-year tenure with the company, he has played a critical role in the success of our lab water business and has helped transform our Bioscience business into a major player in the worldwide life science industry. We are thrilled to welcome Jon as President of the Bioscience Division and look forward to the continued growth of the division under his leadership.”

“I am honored to lead Millipore’s Bioscience Division during this dynamic and exciting time in our industry,” noted DiVincenzo. “Emerging technologies and advances in life science research give us an unprecedented opportunity to help solve some of the world’s most challenging human health issues. I look forward to further strengthening our core bioscience capabilities and partnering with customers around the world to advance their important work.”